CoChat

Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke

Open access

The DOI matches its Crossref record; 42 of the 43 references it cites were found in a registry or an index.

Abstract

Metformin expands the neural precursor pool in adult females, but not males, and is correlated with cognitive recovery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/sciadv.aax1912

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 In vitro and in vivo metformin treatment leads to an age- and sex-dependent expansion of the NSC pool. (A and B) Fold change in the number of neurospheres from the SVZ of neonatal (P8), juvenile (P17), and adult (7 weeks) females [(A) neonate: −Met, n = 16 mice; +Met, n = 16 mice; P < 0.001; juvenile: −Met, n = 7 mice; +Met, n = 7 mice; adult: −Met, n = 15 mice; +Met, n = 15 mice; over three to seven independent experiments per age group, P < 0.05; Student’s t test] and males [(B) neonate: −Met, n = 15 mice; +Met, n = 15 mice; P < 0.001; juvenile: −Met, n = 10 mice; +Met, n = 10 mice; adult: −Met, n = 11 mice; +Met, n = 11 mice; over four to five independent experiments per age group, Student’s t test] following in vitro metformin administration (1 μM). (C and D) Fold change in the number of neurospheres from the SVZ of neonatal (P8), juvenile (P17), and adult (7 weeks) females [(C) neonate: −Met, n = 4 mice; +Met, n = 5 mice; P < 0.05; juvenile: −Met, n = 9 mice; +Met, n = 8 mice; adult: −Met, n = 10 mice; +Met, n = 8 mice; P < 0.05; over three to five independent experiments per age group, Student’s t test] and males [(D) neonate: −Met, n = 6 mice; +Met, n = 6 mice; P < 0.05; juvenile: −Met, n = 6 mice; +Met, n = 5 mice; adult: −Met, n = 7 mice; +Met, n = 5 mice; over three to four independent experiments per age group, Student’s t test] following in vivo administration with vehicle or metformin (20 or 200 mg/kg). Experiments across different ages were analyzed using a Student’s t test. *P < 0.05, ***P < 0.005, ****P < 0.001. Met, metformin.
Fig. 1 In vitro and in vivo metformin treatment leads to an age- and sex-dependent expansion of the NSC pool. (A and B) Fold change in the number of neurospheres from the SVZ of neonatal (P8), juvenile (P17), and adult (7 weeks) females [(A) neonate: −Met, n = 16 mice; +Met, n = 16 mice; P < 0.001; juvenile: −Met, n = 7 mice; +Met, n = 7 mice; adult: −Met, n = 15 mice; +Met, n = 15 mice; over three to seven independent experiments per age group, P < 0.05; Student’s t test] and males [(B) neonate: −Met, n = 15 mice; +Met, n = 15 mice; P < 0.001; juvenile: −Met, n = 10 mice; +Met, n = 10 mice; adult: −Met, n = 11 mice; +Met, n = 11 mice; over four to five independent experiments per age group, Student’s t test] following in vitro metformin administration (1 μM). (C and D) Fold change in the number of neurospheres from the SVZ of neonatal (P8), juvenile (P17), and adult (7 weeks) females [(C) neonate: −Met, n = 4 mice; +Met, n = 5 mice; P < 0.05; juvenile: −Met, n = 9 mice; +Met, n = 8 mice; adult: −Met, n = 10 mice; +Met, n = 8 mice; P < 0.05; over three to five independent experiments per age group, Student’s t test] and males [(D) neonate: −Met, n = 6 mice; +Met, n = 6 mice; P < 0.05; juvenile: −Met, n = 6 mice; +Met, n = 5 mice; adult: −Met, n = 7 mice; +Met, n = 5 mice; over three to four independent experiments per age group, Student’s t test] following in vivo administration with vehicle or metformin (20 or 200 mg/kg). Experiments across different ages were analyzed using a Student’s t test. *P < 0.05, ***P < 0.005, ****P < 0.001. Met, metformin.CC BY-NC · PubMed Central
Fig. 2 Estradiol in the female niche is sufficient for the metformin-induced expansion of the NSC pool. (A) Experimental paradigm and fold change in the number of neurospheres from the SVZ of female juvenile mice that received estradiol (5.6 mg/kg) or vehicle for 11 days and metformin (200 mg/kg) or vehicle for 7 days in vivo (Est + vehicle, n = 9 mice; Est + Met, n = 8 mice; over five independent experiments; P < 0.05; Student’s t test). (B) Experimental paradigm and fold change in the number of neurospheres from control and ovariectomized mice following administration of vehicle or metformin (200 mg/kg) for 1 week in vivo (Ov + vehicle, n = 8 mice; Ov + Est, n = 8 mice; over three independent experiments; Student’s t test). (C) Fold change in the number of neurospheres passaged in the presence or absence of 1 μM metformin in vitro (−Met, n = 7 mice; +Met, n = 7 mice; over four experiments; Student’s t test). *P < 0.05. Est, estradiol; Met, metformin; Ov, ovariectomized; n.s., not significant.
Fig. 2 Estradiol in the female niche is sufficient for the metformin-induced expansion of the NSC pool. (A) Experimental paradigm and fold change in the number of neurospheres from the SVZ of female juvenile mice that received estradiol (5.6 mg/kg) or vehicle for 11 days and metformin (200 mg/kg) or vehicle for 7 days in vivo (Est + vehicle, n = 9 mice; Est + Met, n = 8 mice; over five independent experiments; P < 0.05; Student’s t test). (B) Experimental paradigm and fold change in the number of neurospheres from control and ovariectomized mice following administration of vehicle or metformin (200 mg/kg) for 1 week in vivo (Ov + vehicle, n = 8 mice; Ov + Est, n = 8 mice; over three independent experiments; Student’s t test). (C) Fold change in the number of neurospheres passaged in the presence or absence of 1 μM metformin in vitro (−Met, n = 7 mice; +Met, n = 7 mice; over four experiments; Student’s t test). *P < 0.05. Est, estradiol; Met, metformin; Ov, ovariectomized; n.s., not significant.CC BY-NC · PubMed Central
Fig. 3 Testosterone inhibits the metformin-induced expansion of the stem cell pool. (A) Experimental paradigm and fold change in the number of neurospheres from the SVZ of male juvenile mice that received estradiol (5.6 mg/kg) or vehicle for 11 days and metformin (200 mg/kg) or vehicle for 7 days in vivo (Est + vehicle, n = 5 mice; Est + Met, seven mice from three to four independent experiments, Student’s t test). (B) Experimental paradigm and fold change in the number of neurospheres from male neonatal mice that received testosterone only or testosterone and metformin for 4 days in vivo (Test + vehicle, n = 7 mice; Test + Met, n = 7 mice over seven independent experiments; Student’s t test). (C) Experimental paradigm and fold change in the number of neurospheres from control and castrated males following vehicle or metformin (200 mg/kg) administration for 1 week in vivo (Cast + vehicle, n = 9 mice; Cast + Met, n = 9 mice; over three independent experiments; P < 0.05; Student’s t test). (D) Fold change in the number of neurospheres passaged in the presence or absence of 1 μM metformin in vitro (−Met, n = 7 mice; +Met, n = 7 mice; over four experiments; P < 0.01; Student’s t test). (E) Coculture paradigm and fold change in the number of neurospheres from YFP male cells plated in an overwhelmingly female environment, in the presence or absence of 1 μM metformin, in vitro (n = 9 independent experiments, P < 0.05, Student’s t test). (F) Coculture paradigm and fold change in the number of neurospheres from YFP female cells plated in an overwhelmingly male environment in the presence or absence of 1 μM metformin in vitro (n = 8 independent experiments, P < 0.05, Student’s t test). *P < 0.05, **P < 0.01. Cast, castrated; Est, estradiol; Met, metformin; Test, testosterone.
Fig. 3 Testosterone inhibits the metformin-induced expansion of the stem cell pool. (A) Experimental paradigm and fold change in the number of neurospheres from the SVZ of male juvenile mice that received estradiol (5.6 mg/kg) or vehicle for 11 days and metformin (200 mg/kg) or vehicle for 7 days in vivo (Est + vehicle, n = 5 mice; Est + Met, seven mice from three to four independent experiments, Student’s t test). (B) Experimental paradigm and fold change in the number of neurospheres from male neonatal mice that received testosterone only or testosterone and metformin for 4 days in vivo (Test + vehicle, n = 7 mice; Test + Met, n = 7 mice over seven independent experiments; Student’s t test). (C) Experimental paradigm and fold change in the number of neurospheres from control and castrated males following vehicle or metformin (200 mg/kg) administration for 1 week in vivo (Cast + vehicle, n = 9 mice; Cast + Met, n = 9 mice; over three independent experiments; P < 0.05; Student’s t test). (D) Fold change in the number of neurospheres passaged in the presence or absence of 1 μM metformin in vitro (−Met, n = 7 mice; +Met, n = 7 mice; over four experiments; P < 0.01; Student’s t test). (E) Coculture paradigm and fold change in the number of neurospheres from YFP male cells plated in an overwhelmingly female environment, in the presence or absence of 1 μM metformin, in vitro (n = 9 independent experiments, P < 0.05, Student’s t test). (F) Coculture paradigm and fold change in the number of neurospheres from YFP female cells plated in an overwhelmingly male environment in the presence or absence of 1 μM metformin in vitro (n = 8 independent experiments, P < 0.05, Student’s t test). *P < 0.05, **P < 0.01. Cast, castrated; Est, estradiol; Met, metformin; Test, testosterone.CC BY-NC · PubMed Central
Fig. 4 Metformin has sex-dependent effects on proliferation but enhances neurogenesis in both females and males. (A) Experimental paradigm. (B) Average number of BrdU+ cells in the SVZ of adult females treated with vehicle or Met (200 mg/kg) for 1 week (Vehicle, n = 4 mice; Met, n = 4 mice; P < 0.05; Student’s t test). (C) BrdU+ cells (arrows) in the SVZ of vehicle- or Met-treated female mice. (D) Average number of BrdU+ cells in the SVZ of adult males treated with vehicle or Met (200 mg/kg) for 1 week (Vehicle, n = 3 mice; Met, n = 3 mice; Student’s t test). (E) BrdU+ cells (arrows) in the SVZ of vehicle- or Met-treated male mice. (F) Experimental paradigm. (G) Average number of Ki67 + Dcx + cells in the SVZ of female mice that received Met (200 mg/kg) for 1 week in vivo (Vehicle, n = 5 mice; Met, n = 5 mice; P < 0.05; Student’s t test). (H) Ki67+Dcx+ cells (arrowheads) in the SVZ of vehicle- or Met-treated female mice. (I) Average number of Ki67 + Dcx + cells in the SVZ of male mice that received Met (200 mg/kg) for 1 week in vivo (Vehicle, n = 4 mice; Met, n = 3 mice; P < 0.05; Student’s t test). (J) Ki67+Dcx+ cells (arrowheads) in the SVZ of vehicle- or Met-treated male mice. *P < 0.05. Scale bars, 50 μm. CC, corpus callosum; Dcx, doublecortin; LV, lateral ventricle; Met, metformin; Veh, vehicle.
Fig. 4 Metformin has sex-dependent effects on proliferation but enhances neurogenesis in both females and males. (A) Experimental paradigm. (B) Average number of BrdU+ cells in the SVZ of adult females treated with vehicle or Met (200 mg/kg) for 1 week (Vehicle, n = 4 mice; Met, n = 4 mice; P < 0.05; Student’s t test). (C) BrdU+ cells (arrows) in the SVZ of vehicle- or Met-treated female mice. (D) Average number of BrdU+ cells in the SVZ of adult males treated with vehicle or Met (200 mg/kg) for 1 week (Vehicle, n = 3 mice; Met, n = 3 mice; Student’s t test). (E) BrdU+ cells (arrows) in the SVZ of vehicle- or Met-treated male mice. (F) Experimental paradigm. (G) Average number of Ki67 + Dcx + cells in the SVZ of female mice that received Met (200 mg/kg) for 1 week in vivo (Vehicle, n = 5 mice; Met, n = 5 mice; P < 0.05; Student’s t test). (H) Ki67+Dcx+ cells (arrowheads) in the SVZ of vehicle- or Met-treated female mice. (I) Average number of Ki67 + Dcx + cells in the SVZ of male mice that received Met (200 mg/kg) for 1 week in vivo (Vehicle, n = 4 mice; Met, n = 3 mice; P < 0.05; Student’s t test). (J) Ki67+Dcx+ cells (arrowheads) in the SVZ of vehicle- or Met-treated male mice. *P < 0.05. Scale bars, 50 μm. CC, corpus callosum; Dcx, doublecortin; LV, lateral ventricle; Met, metformin; Veh, vehicle.CC BY-NC · PubMed Central
Fig. 5 Long-term metformin treatment leads to cognitive improvements in females, but not males, following early postnatal H-I injury. (A) Experimental paradigm. (B) Trial times in the puzzle box task for female mice comparing naïve (uninjured), H-I injured, and H-I+ metformin-treated cohorts (Naïve, n = 11 mice; H-I, n = 13 mice; H-I + Met, n = 15 mice; *P < 0.05, **P < 0.01, F8,288 = 31.73) repeated-measures two-way ANOVA). (C) Trial times in the puzzle box task for male mice comparing naïve (uninjured), H-I injured, and H-I + metformin-treated cohorts, which resulted in a trial effect (Naïve, n = 8 mice; H-I, n = 11 mice; H-I + Met, n = 13 mice; *P < 0.05, **P < 0.01, F8,232 = 32.93 repeated-measures two-way ANOVA). *P < 0.05, **P < 0.01. Met, metformin.
Fig. 5 Long-term metformin treatment leads to cognitive improvements in females, but not males, following early postnatal H-I injury. (A) Experimental paradigm. (B) Trial times in the puzzle box task for female mice comparing naïve (uninjured), H-I injured, and H-I+ metformin-treated cohorts (Naïve, n = 11 mice; H-I, n = 13 mice; H-I + Met, n = 15 mice; *P < 0.05, **P < 0.01, F8,288 = 31.73) repeated-measures two-way ANOVA). (C) Trial times in the puzzle box task for male mice comparing naïve (uninjured), H-I injured, and H-I + metformin-treated cohorts, which resulted in a trial effect (Naïve, n = 8 mice; H-I, n = 11 mice; H-I + Met, n = 13 mice; *P < 0.05, **P < 0.01, F8,232 = 32.93 repeated-measures two-way ANOVA). *P < 0.05, **P < 0.01. Met, metformin.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 42 references

Cited by

See all 85

Metadata

Authors
Ruddy, R. M., Adams, K. V., & Morshead, C. M.
Affiliations
University of Toronto (CA)
Corresponding author
Morshead, Cindi M.
Venue
Science Advances
Published
2019-09-06
Volume
5
Issue
9
Pages
eaax1912-eaax1912
ISSN
2375-2548 (ISSN-L)
OpenAlex
W2973088617
Cited by
82
References
43
Citations by year
2026: 4 · 2025: 7 · 2024: 12 · 2023: 17 · 2022: 18 · 2021: 15 · 2020: 8 · 2019: 1
FWCI
3.94
Type
journal article
Language
en
Open access
Licence
cc-by-nc
Locations
  • Science Advances (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
  • Ontario Brain Institute
  • Fondation Brain Canada
  • Canadian Institutes of Health Research
  • Stem Cell Network
  • Ontario Institute for Regenerative Medicine
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Neonatal and fetal brain pathology
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
metformin, neural progenitor cells, neonatal stroke, sex differences, age-dependent effects, subventricular zone, cognitive recovery, functional recovery, brain injury, neurogenesis, sex hormones
MeSH terms
Animals, Animals, Newborn, Cell Differentiation, Cell Movement, Cognition Disorders, Disease Models, Animal, Female, Hypoglycemic Agents, Male, Metformin, Mice, Inbred C57BL, Neurons, Signal Transduction, Stroke, Mice, Neurogenesis, Neural Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke. https://app.cochat.ai/papers/10.1126/sciadv.aax1912
The paper
Ruddy, R. M., Adams, K. V., & Morshead, C. M. (2019). Age- and sex-dependent effects of metformin on neural precursor cells and cognitive recovery in a model of neonatal stroke. Science Advances. https://doi.org/10.1126/sciadv.aax1912

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.